Navigation Links
Vectibix® (Panitumumab) Granted Approval for Expanded Indications in the European Union
Date:11/15/2011

terstitial pneumonitis or pulmonary fibrosis. Vectibix should not be administered in combination with oxaliplatin-containing chemotherapy to mCRC patients with mutant KRAS tumors or for whom KRAS tumor status is unknown.
  • Adverse events of special importance associated with Vectibix and/or EGFR monoclonal antibody therapies include dermatologic-related reactions, pulmonary complications, electrolyte disturbances, infusion-related reactions (including rare reports with fatal outcome) and ocular toxicities. Acute renal failure has been observed in patients who develop severe diarrhea and dehydration. These events should be monitored carefully, see Summary of Product Characteristics for information on appropriate management of these adverse events.
  • Vectibix should not be used in combination with IFL chemotherapy or in combination with bevacizumab containing chemotherapy. For patients with ECOG 2 performance status, assessment of benefit-risk is recommended prior to initiation of Vectibix in combination with chemotherapy for treatment of mCRC.

  • About Amgen

    Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

    Forward-Looking Statements

    This news release contains forward-looking statements that a
    '/>"/>

    SOURCE Amgen Europe GmbH
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Amgen to Appeal CHMP Opinion on Vectibix® (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer in Europe
    2. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
    3. Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkins Lymphoma
    4. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
    5. Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery
    6. Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
    7. Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency
    8. Emphasys Medical Granted Expedited Review From FDA for Zephyr(R) Endobronchial Valve
    9. Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
    10. Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Acute Myelogenous Leukemia
    11. Inclusion of Six-Year Overall Survival Data in the Eloxatin(R) (oxaliplatin injection) Prescribing Information Granted FDA Priority Review
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ... the "Dental Consumables Market - Global Industry ... - 2018" report to their offering. ... ) Dental consumables are products which are ... impairments, for tooth restoration and in treatment of ...
    (Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading ... company, awarded several new IT value-added reseller (VAR) ... hospital organizations with IT goods and services at ... agreements, as well as value-added services such as ... New Novation agreements were awarded to ...
    (Date:1/15/2014)... DUBLIN , January 15, 2014 ... that it has waived the Office of Fair Trading (OFT) ... the outstanding shares of ViroPharma Incorporated (NASDAQ: VPHM).   ... no longer conditional on OFT approval, and Shire expects to ... currently scheduled expiration time, subject to the satisfaction of all ...
    Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
    ... Cardiac Science Corporation (Nasdaq: CSCX ), a ... ) and diagnostic cardiac monitoring devices, announced today it appointed ... of directors. Andrews replaces long-time board member Jue-Hsien Chern, Ph.D., ... The total number of directors remains at six. , ...
    ... (Nasdaq: ITMN ) today announced results from operations for the ... InterMune reported a net loss for the third quarter of ... net loss of $14.0 million, or $0.36 per share, in the ... and President of InterMune, said, "The third quarter and recent weeks ...
    Cached Medicine Technology:Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 2Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 3Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 4Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 5InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 2InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 3InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 4InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 5InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 7InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 8InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 9InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 10InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 11InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 12InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 13
    (Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
    (Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
    (Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
    (Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
    (Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
    Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
    ... , ... Movement, a new coalition under the leadership of Matthias Rath, MD, is spearheading an online ... and defend the rights of Americans to access safe, science-based, natural health alternatives. , ... Santa Clara, CA (PRWEB) June 29, ...
    ... , ... According to the US Drug Watchdog, "we want to hear ... lost their sense of smell." The group says, "on June 16, 2009, ... marketed over-the-counter as cold remedies because they are associated with the loss ...
    ... ... for Asia Adult Expo (AAE) for the second consecutive year. , ... Macau (PRWEB) June 28, 2009 -- Macau.com, the leading ... agency for Asia Adult Expo (AAE) for the second consecutive year., , , , ...
    ... incontinence and more can result, research shows , SUNDAY, ... problem, it turns out, is associated with potentially significant ... of the scientific evidence, researchers found that constipation might ... complications such as hemorrhoids, anal fissures, fecal incontinence, colonic ...
    ... AcademyHealth announced its 2009 award winners today, recognizing leading ... contributions for the fields of health services research and ... by distinguished leaders from our field, honor new and ... improve health and health care," said W. David Helms, ...
    ... sports injury , SATURDAY, June 27 (HealthDay News) -- If ... your chance of getting hurt during your pursuit of recreation. ... injury, the rates could be reduced significantly if athletes took ... Dr. Victor Khabie, chief of orthopedic surgery and sports medicine ...
    Cached Medicine News:Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 2Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 3Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 4Health News:Americans' Right to Access Natural Health Alternatives in Peril, Says Natural Health Freedom Movement 5Health News:The US Drug Watchdog Expands its Zicam Investigation and Wants to Hear From All Users Who Lost Their Sense of Smell 2Health News:Macau.com Partners With Asia Adult Expo As Official Travel Company 2Health News:Macau.com Partners With Asia Adult Expo As Official Travel Company 3Health News:Constipation May Lead to Other Problems 2Health News:Constipation May Lead to Other Problems 3Health News:AcademyHealth honors leading health services researchers 2
    ... The Nightingale Monitoring System™ expands hospital-grade monitoring ... of subacute care and disease state management. ... ability to encompass a full range of ... patients inside the hospital, to periodic monitoring ...
    ... FlexNet adds wireless capability to ... This expands the Flexible Monitoring concept ... patient information from anywhere to anywhere. ... ambulatory wireless monitors and hardwired and ...
    ... Propaq CS makes the ... Propaq CS even more ... Symbol Technologies, the Wireless ... wireless ethernet Local Area ...
    ... Welch Allyn Vital Signs Monitor ... clinical areas that don't require ... to use, each monitor comes ... and optional features include Nellcor ...
    Medicine Products: